Promising Safety and Efficacy Results for Supraflex Cruz in HBR Subset Analysis from FIRE Trial with 1Month DAPT
SMT (Sahajanand Medical Technologies), a renowned medical device company at the forefront of innovative patient care in the cardiovascular segment, has made an announcement about the Fire Trial in HBR patients at the prestigious TCT (Transcatheter Cardiovascular Therapeutics) Conference, held in California.
The FIRE trial was designed to evaluate a strategy of physiology-guided complete myocardial revascularization in comparison to...











































